These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1474 related items for PubMed ID: 9578596
1. Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations. Lasker JM, Wester MR, Aramsombatdee E, Raucy JL. Arch Biochem Biophys; 1998 May 01; 353(1):16-28. PubMed ID: 9578596 [Abstract] [Full Text] [Related]
2. CYP2C19 participates in tolbutamide hydroxylation by human liver microsomes. Wester MR, Lasker JM, Johnson EF, Raucy JL. Drug Metab Dispos; 2000 Mar 01; 28(3):354-9. PubMed ID: 10681382 [Abstract] [Full Text] [Related]
3. Human CYP2C19 is a major omeprazole 5-hydroxylase, as demonstrated with recombinant cytochrome P450 enzymes. Karam WG, Goldstein JA, Lasker JM, Ghanayem BI. Drug Metab Dispos; 1996 Oct 01; 24(10):1081-7. PubMed ID: 8894508 [Abstract] [Full Text] [Related]
4. Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4'-hydroxylation activities in livers of Japanese and Caucasian populations. Inoue K, Yamazaki H, Imiya K, Akasaka S, Guengerich FP, Shimada T. Pharmacogenetics; 1997 Apr 01; 7(2):103-13. PubMed ID: 9170147 [Abstract] [Full Text] [Related]
5. Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes. Miyazawa M, Shindo M, Shimada T. Drug Metab Dispos; 2002 May 01; 30(5):602-7. PubMed ID: 11950794 [Abstract] [Full Text] [Related]
6. Cytochrome P450 2C9 catalyzes indomethacin O-demethylation in human liver microsomes. Nakajima M, Inoue T, Shimada N, Tokudome S, Yamamoto T, Kuroiwa Y. Drug Metab Dispos; 1998 Mar 01; 26(3):261-6. PubMed ID: 9492390 [Abstract] [Full Text] [Related]
7. Cynomolgus monkey cytochrome P450 2C43: cDNA cloning, heterologous expression, purification and characterization. Mitsuda M, Iwasaki M, Asahi S. J Biochem; 2006 May 01; 139(5):865-72. PubMed ID: 16751594 [Abstract] [Full Text] [Related]
8. Relative quantities of catalytically active CYP 2C9 and 2C19 in human liver microsomes: application of the relative activity factor approach. Venkatakrishnan K, von Moltke LL, Greenblatt DJ. J Pharm Sci; 1998 Jul 01; 87(7):845-53. PubMed ID: 9649353 [Abstract] [Full Text] [Related]
9. The role of CYP2C in the in vitro bioactivation of the contraceptive steroid desogestrel. Gentile DM, Verhoeven CH, Shimada T, Back DJ. J Pharmacol Exp Ther; 1998 Dec 01; 287(3):975-82. PubMed ID: 9864282 [Abstract] [Full Text] [Related]
10. Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes. Yamazaki H, Shimada T. Arch Biochem Biophys; 1997 Oct 01; 346(1):161-9. PubMed ID: 9328296 [Abstract] [Full Text] [Related]
12. Relative contributions of CYP2C9 and 2C19 to phenytoin 4-hydroxylation in vitro: inhibition by sulfaphenazole, omeprazole, and ticlopidine. Giancarlo GM, Venkatakrishnan K, Granda BW, von Moltke LL, Greenblatt DJ. Eur J Clin Pharmacol; 2001 Apr 01; 57(1):31-6. PubMed ID: 11372587 [Abstract] [Full Text] [Related]
13. Different contributions of cytochrome P450 2C19 and 3A4 in the oxidation of omeprazole by human liver microsomes: effects of contents of these two forms in individual human samples. Yamazaki H, Inoue K, Shaw PM, Checovich WJ, Guengerich FP, Shimada T. J Pharmacol Exp Ther; 1997 Nov 01; 283(2):434-42. PubMed ID: 9353355 [Abstract] [Full Text] [Related]
14. Oxidative metabolism of omeprazole in human liver microsomes: cosegregation with S-mephenytoin 4'-hydroxylation. Chiba K, Kobayashi K, Manabe K, Tani M, Kamataki T, Ishizaki T. J Pharmacol Exp Ther; 1993 Jul 01; 266(1):52-9. PubMed ID: 8331574 [Abstract] [Full Text] [Related]
15. Evidence that CYP2C19 is the major (S)-mephenytoin 4'-hydroxylase in humans. Goldstein JA, Faletto MB, Romkes-Sparks M, Sullivan T, Kitareewan S, Raucy JL, Lasker JM, Ghanayem BI. Biochemistry; 1994 Feb 22; 33(7):1743-52. PubMed ID: 8110777 [Abstract] [Full Text] [Related]
16. Regioselective and stereoselective metabolism of ibuprofen by human cytochrome P450 2C. Hamman MA, Thompson GA, Hall SD. Biochem Pharmacol; 1997 Jul 01; 54(1):33-41. PubMed ID: 9296349 [Abstract] [Full Text] [Related]
17. Human CYP2C-mediated stereoselective phenytoin hydroxylation in Japanese: difference in chiral preference of CYP2C9 and CYP2C19. Yasumori T, Chen LS, Li QH, Ueda M, Tsuzuki T, Goldstein JA, Kato R, Yamazoe Y. Biochem Pharmacol; 1999 Jun 01; 57(11):1297-303. PubMed ID: 10230773 [Abstract] [Full Text] [Related]
18. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4. Feierman DE, Lasker JM. Drug Metab Dispos; 1996 Sep 01; 24(9):932-9. PubMed ID: 8886601 [Abstract] [Full Text] [Related]
19. Interaction of delavirdine with human liver microsomal cytochrome P450: inhibition of CYP2C9, CYP2C19, and CYP2D6. Voorman RL, Payne NA, Wienkers LC, Hauer MJ, Sanders PE. Drug Metab Dispos; 2001 Jan 01; 29(1):41-7. PubMed ID: 11124228 [Abstract] [Full Text] [Related]
20. Identification of human CYP2C19 residues that confer S-mephenytoin 4'-hydroxylation activity to CYP2C9. Tsao CC, Wester MR, Ghanayem B, Coulter SJ, Chanas B, Johnson EF, Goldstein JA. Biochemistry; 2001 Feb 20; 40(7):1937-44. PubMed ID: 11329260 [Abstract] [Full Text] [Related] Page: [Next] [New Search]